# The Cigna Group (CI) FY2024 Annual P&L / Income Statement

- Company: The Cigna Group (CI)
- Period: 2024-01-01 to 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-27, accession number 0001739940-25-000009
- Page: https://plicit.ai/financials/ci/fy2024-annual-income-statement
- Chart image: https://plicit.ai/charts/ci-fy2024-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service (4 categories)

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **TOTAL REVENUES**: 247,121,000,000 US dollars
- **TOTAL BENEFITS AND EXPENSES**: 237,704,000,000 US dollars
- **Income from operations**: 9,417,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 4,148,000,000 US dollars
- **Income before income taxes**: 5,269,000,000 US dollars
- **TOTAL INCOME TAXES**: 1,491,000,000 US dollars
- **Net income**: 3,778,000,000 US dollars
- **Pharmacy revenues**: 185,362,000,000 US dollars
- **Fees and other revenues**: 14,790,000,000 US dollars
- **Premiums**: 45,996,000,000 US dollars
- **Net investment income**: 973,000,000 US dollars
- **Pharmacy and other service costs**: 182,509,000,000 US dollars
- **Medical costs and other benefit expenses**: 38,648,000,000 US dollars
- **Selling, general and administrative expenses**: 14,844,000,000 US dollars
- **Amortization of acquired intangible assets**: 1,703,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to The Cigna Group: $3.43 B; to noncontrolling interests: $344.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/ci/fy2024-annual-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/ci-fy2024-annual-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **TOTAL REVENUES**: 247,121,000,000 US dollars
- **TOTAL BENEFITS AND EXPENSES**: 237,704,000,000 US dollars
- **Income from operations**: 9,417,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 4,148,000,000 US dollars
- **Income before income taxes**: 5,269,000,000 US dollars
- **TOTAL INCOME TAXES**: 1,491,000,000 US dollars
- **Net income**: 3,778,000,000 US dollars
- **Evernorth Health Services**: 201,973,000,000 US dollars
- **Cigna Healthcare**: 53,118,000,000 US dollars
- **Other Operations**: 828,000,000 US dollars
- **Pharmacy and other service costs**: 182,509,000,000 US dollars
- **Medical costs and other benefit expenses**: 38,648,000,000 US dollars
- **Selling, general and administrative expenses**: 14,844,000,000 US dollars
- **Amortization of acquired intangible assets**: 1,703,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 255,919,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Corporate and Eliminations**: negative 8,798,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to The Cigna Group: $3.43 B; to noncontrolling interests: $344.00 M.
